Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from the second large clinical validation study of Oncotype DX® in patients with a pre-invasive form of breast cancer known as DCIS (ductal carcinoma in situ). The study, conducted by the Ontario DCIS Study Group of Sunnybrook …
Source:Genomic Health reports positive results from Oncotype DX clinical study in women with DCIS
Saturday, December 13, 2014
Genomic Health reports positive results from Oncotype DX clinical study in women with DCIS
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment